Clarivate Plc (CLVT)
NYSE: CLVT · Real-Time Price · USD
2.910
+0.100 (3.56%)
At close: Jan 22, 2026, 4:00 PM EST
2.930
+0.020 (0.69%)
After-hours: Jan 22, 2026, 7:00 PM EST
Clarivate Revenue
Clarivate had revenue of $623.10M in the quarter ending September 30, 2025, with 0.31% growth. This brings the company's revenue in the last twelve months to $2.56B, down -2.38% year-over-year. In the year 2024, Clarivate had annual revenue of $2.56B, down -2.74%.
Revenue (ttm)
$2.56B
Revenue Growth
-2.38%
P/S Ratio
0.77
Revenue / Employee
$208,433
Employees
12,000
Market Cap
1.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.56B | -72.10M | -2.74% |
| Dec 31, 2023 | 2.63B | -31.00M | -1.17% |
| Dec 31, 2022 | 2.66B | 782.90M | 41.71% |
| Dec 31, 2021 | 1.88B | 902.56M | 92.63% |
| Dec 31, 2019 | 974.35M | 5.88M | 0.61% |
| Dec 31, 2018 | 968.47M | 50.83M | 5.54% |
| Dec 31, 2017 | 917.63M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DXC Technology Company | 12.71B |
| Concentrix | 9.83B |
| ASGN Incorporated | 3.99B |
| Formula Systems (1985) | 3.02B |
| NCR Voyix | 2.65B |
| Globant | 2.48B |
| VNET Group | 1.34B |
| Magic Software Enterprises | 603.22M |
CLVT News
- 14 hours ago - Top 3 Industrials Stocks You'll Regret Missing This Quarter - Benzinga
- 17 hours ago - Clarivate Introduces Nexus, Connecting AI Users to Trusted Academic Resources - PRNewsWire
- 1 day ago - Clarivate Reveals Top 100 Global Innovators 2026 - PRNewsWire
- 14 days ago - CCC Intelligent Solutions Introduces OEM Repair Certification Management Solution - GlobeNewsWire
- 16 days ago - Wall Street Breakfast Podcast: DHS Calls Out Hilton Over ICE - Seeking Alpha
- 16 days ago - Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report - PRNewsWire
- 5 weeks ago - Nissan Selects IPfolio from Clarivate - PRNewsWire
- 5 weeks ago - CCC Announces $500 Million Share Repurchase Authorization and $300 Million Accelerated Share Repurchase Program - GlobeNewsWire